In the News... Walmart's new insulin, Omnipod 5 studies, stem cell updates & more!
Diabetes Connections | Type 1 Diabetes
Release Date: 07/02/2021
What’s ahead for Tandem Diabetes? An update on pumps, CGMs, infusion sets, and more!
Diabetes Connections | Type 1 Diabetes
This week on Diabetes Connections, Tandem Diabetes made some big announcements at the recent ADA Conference – we’re going behind the headlines and asking your questions about Control IQ updates, extended wear infusion sets, what’s happening with their patch pumps, and a lot more. I’m talking to Ben Mar the Director of Product marketing. We also getting into their expanded partnership with Abbott – in additional to the Libre 3 plus, they’re one of the pump companies that has signed on for the future glucose/ketone sensor. A lot to get to here! This podcast is not intended as medical...
info_outline
In the News...Top Stories from ADA and more!
Diabetes Connections | Type 1 Diabetes
It's In the News.. a look at the top headlines and stories in the diabetes community. This week's top stories: loads of news from American Diabetes Association Scientific Sessions, GLP1 for T1D, Tech updates, diabetes in space, and more! Find out more about Please visit our Sponsors & Partners - they help make the show possible! Learn more about from extreme temperatures The best way to keep up with Stacey and the show is by signing up for our weekly newsletter: Here's where to find us: Learn more about everything at our home page Reach...
info_outline
Still Not Waiting: Lane Desborough's Bold New Push with Nudge
Diabetes Connections | Type 1 Diabetes
This week on Diabetes Connections, “We are not waiting” became more than just a slogan — it sparked a movement. Back when the diabetes community was fed up with slow progress, DIYers stepped in with solutions that actually worked better than what companies were offering. That rallying cry? It came from Lane Desborough in 2013. And more than a decade later, he’s still challenging the status quo. We’re catching up with Lane to talk about his latest project, Nudge — much more than just another insulin pump algorithm, it’s an innovation to create more open and accessible systems This...
info_outline
Cloak the Poke: A New Way to Make Shots Less Scary
Diabetes Connections | Type 1 Diabetes
As we gear up for ADA Scientific Sessions and get ready to hear studies and reports from the big diabetes companies, I’ve decided to highlight something on the other end of the spectrum. College students, seeing a need and developing a solution. Cloak The Poke is all about addressing fear of needles, especially in kids. We’ll explain how it works, more about the team behind it, and their big goals going forward. This podcast is not intended as medical advice. If you have those kinds of questions, please contact your health care provider. More about Join us at Please visit...
info_outline
In the News... Omnipod updates, Tandem + Abbott, Dr. Pepper Zero recall, American Ninja and more!
Diabetes Connections | Type 1 Diabetes
It's In the News.. a look at the top headlines and stories in the diabetes community. This week's top stories: what is adaptive biobehavioral control for AID systems? Omnipod 5 launches iOS app with Dexcom G7 compatability and a comic book(?!), Tandem and Abbott announce new partnership, Katie Bone is back on American Ninja Warrior, and more! Find out more about Please visit our Sponsors & Partners - they help make the show possible! Learn more about from extreme temperatures The best way to keep up with Stacey and the show is by signing up for our...
info_outline
GLP-1 Medications for T1D: What your endo wants you to know
Diabetes Connections | Type 1 Diabetes
More and more people with type 1 are using GLP-1 receptor agonists. You know these medications, with brand names like Ozempic, Mounjaro, Wegovy and Zepbound, but none of them are specifically approved to treat T1D. Some of the first studies are underway to study the safety and effectiveness of GLP-1s, but that hasn’t stopped thousands of using them off-label or to treat obesity. We’re talking to an endocrinologist and a clinical pharmacist about why they prescribe these meds to some of their type 1 patients, who they won’t prescribe them for, and – I know you’re already asking –...
info_outline
Why Diabetes Camp Matters More Than Ever: A Conversation with DECA’s Lisa Gier
Diabetes Connections | Type 1 Diabetes
It’s time to talk about summer camp! Kids may be getting ready to go, already there, or maybe you’re an adult with type 1 who has fond memories or is working at camp. We’re talking to the which serves the diabetes camp community. Lisa Gier is the executive direction of DECA – she lives with type 1, attended camp and her son who also has T1D now goes to the camp she attended as a child. This podcast is not intended as medical advice. If you have those kinds of questions, please contact your health care provider. Join us at Please visit our Sponsors &...
info_outline
Tubeless, smarter & interoperable: A look into Medtronic’s future plans
Diabetes Connections | Type 1 Diabetes
A conversation with a Medtronic engineer who’s been with the company since the beginning of the Artificial Pancreas project. Lou Lintereur is now Chief Engineer for AID systems at Medtronic.. we talk about the recently approved Simplera Sync Sensor, changes coming to Medtronic pumps, he answers your questions about AI use, patch pumps, and the idea of a pump that needs zero user interaction. Note: this episode was recorded before Medtronic's announcement that they will spin off the Diabetes division. This podcast is not intended as medical advice. If you have those kinds of questions, please...
info_outline
"The Worst Game Ever" - Sam Glassenberg wants to change how we learn about T1D
Diabetes Connections | Type 1 Diabetes
Learning through video games isn’t new – there are games aimed at almost every profession, even healthcare. Sam Glassenberg is the founder of Level Ex which makes those types of learning games – and when his daughter was diagnosed with type 1.. he was appalled at the on-boarding process which he called the worst game ever, full of frustration and punishment for the patient and caregiver. So Sam developed Level One – a new free game to teach type 1. We’re talking about how it works, who it’s for, and what makes it different from those gamification flops you may remember...
info_outline
In the News...Tandem's new infusion set approved, Sernova cell-pouch moves forward, GLP-1 meds for T1D, and more!
Diabetes Connections | Type 1 Diabetes
It's In the News.. a look at the top headlines and stories in the diabetes community. This week's top stories: Tandem's new infusion set is approved, Dexcom G7 compatibility with the Omnipod 5 iPhone app announced, Sernova cell-pouch moves forward, GLP-1 meds for T1D, and more! Find out more about Please visit our Sponsors & Partners - they help make the show possible! Learn more about from extreme temperatures The best way to keep up with Stacey and the show is by signing up for our weekly newsletter: Here's where to find us: Learn more...
info_outlineCheck out Stacey's book: The World's Worst Diabetes Mom!
Join the Diabetes Connections Facebook Group!
Sign up for our newsletter here
-----
Use this link to get one free download and one free month of Audible, available to Diabetes Connections listeners!
-----
Get the App and listen to Diabetes Connections wherever you go!
Click here for iPhone Click here for Android
Transcription below:
Hello and welcome to Diabetes Connections In the News! I’m Stacey Simms and these are the top diabetes stories and headlines of the past seven days. As always, I’m going to link up my sources in the Facebook comments – where we are live – and in the show notes at d-c dot com when this airs as a podcast.. so you can read more when you have the time.
XX
In the News is brought to you by Inside the Breakthrough. A new history of science podcast full of “Did You Know… Stuff”
XX
The top story this week - Walmart launches the first-ever and only private brand analog insulin at a discount off the list price.
This new brand ReliOn Novolog will have vials priced at $72 and a package of pens at $85 – compared to the list price of $289 and $558 respectively
Walmart worked directly with Novo Nordisk for the manufacturing of this insulin which will be in regular stores this week and in Sam's Club locations in mid-July.
Interestingly, this price is not below the one offered already by using coupons from groups like GoodRX or even the insulin manufacturers assistance programs. If you need help paying for your insulin, I’ll link up more info on that as well.
https://www.goodrx.com/novolog
XX
As expected, loads of info and studies from the ADA scientific sessions virtual conference that just wrapped up. Please check the links I’ll include because these are just highlights.
XX
Insulet is out with the results of their latest pivotal trial for the Omnipod 5 Automated Insulin Delivery System in very young children. The system improved time in range and reduced A1C in children 2 through just under six. I can tell you from experience, this is a tough age group for many reasons, including the fact that they can’t self-treat or really tell you what’s going on.
Parents and caregivers reported significantly improved sleep quality
Another Omipod 5 study with people aged 6 through 70 showed similar improvements. The system is awaiting FDA approval.
XX
ViaCyte, Inc. released preliminary clinical data from its stem cell-derived islet cell replacement therapy for people with type 1 diabetes. They show the implanted pancreatic cells produced their own insulin – which increase glucose-responsive C-peptide levels, increased time in range, and reduced A1C.
This method protects the stem cells in a pouch – that’s put very simply – Viactye is working on several different methods toward a functional cure.
https://www.prnewswire.com/news-releases/viacyte-reports-compelling-preliminary-clinical-data-from-islet-cell-replacement-therapy-for-patients-with-type-1-diabetes-301320084.html
XX
Another company on the same track.. Sernova Corp also showing their Cell Pouch transplanted with insulin-producing islets is safe and effective. One patient has finished the trial and has now remained insulin independent – that means no requirement for injectable insulin - for 14 months with optimal glucose control.
This is a person who’s lived with type 1 for 47 years..
https://www.thenewswire.com/press-releases/1k3wFKYMv-sernovas-principal-investigator-presents-interim-data-and-positive-patient-outcomes-of-phase-i-ii-t1d-study-at-the-american-diabetes-association-81st-scientific-sessions.html
XX
More from ADA conference - In two small studies, the ultra-rapid acting insulin Afrezza was found to be safe in children with type 1 and adults with type 2 diabetes.
Inhalable insulin is currently only approved for adults so the goal here was to look at safety.. which looks good. But it’s also worth noting that . Time in Range increased from 39% at baseline to 62% which is more than four additional hours spent in range each day!
https://diatribe.org/top-highlights-day-1-ada-scientific-sessions-2021
XX
New info in on Medtronic’s Extended-Wear Infusion Set. This is the pump inset that lasts seven days. This study shows that 75% of the time it makes it to the full seven days – Medtronic’s 3 day infusion sets have a 67% survival rate.
Device failure rates were very low – 8 cases out of more than 3-thousand sessions. Satisfaction was high – with people citing convenience of use, ease of insertion, and comfort of wear. This extended wear set is approved in Europe, available in Finland and has been submitted to the US FDA.
https://diatribe.org/day-2-3-highlights-ada-scientific-sessions-2021
XX
More to come, including news on Control IQ and an endurance athlete starts an amazing new trek.. but first, I want to tell you about one of our great sponsors who helps make Diabetes Connections possible.
- Inside the Breakthrough is a podcast that mixes historical wisdom with modern insight – it’s a science show that’s also entertaining. I love it. They cover everything from snake oil to the actual Eureka moment. There’s even an episode about the guy who discovered the importance of hand washing in hospitals and how no one believed him. And this all actually relates to diabetes! Listen to Inside the Breakthrough wherever you listen to podcasts..
Back to the news…
XX
Control-IQ continues to get high marks. This study looked at adults with an average age of 70 who already had A1Cs around 6.9. Three months after staring Control IQ, time in range increased from 64% to 87% which is 5 and a half hours more each day. All of these adults had prior experience with continuous glucose monitoring and insulin pumps.
XX
Former guest of the podcast, Sébastien Sasseville, is off on a mission to cycle across Canada in 14 days! Sasseville is a Canadian endurance athlete – he lives with type 1 - and it’s going to take about 250 miles a day to get to this goal.
Sasseville says he’s riding to bring attention to the issue of access to technology – he uses the tslim x2 and Dexcom G6 – and to support JDRF Canada’s Access for All campaign. He set off on June 28th and is documenting the journey on social media.
Sebastien Sasseville cycles across Canada: https://www.facebook.com/CanadaRuns.
That’s Diabetes Connections – In the News. If you like it, share it. And feel free to send me your news tips. Stacey @ diabetes dash connections dot com.
Please join me wherever you get podcasts for our next episode -Tuesday – a conversation with Dexcom’s CEO all about the upcoming G7.. I asked him all of your questions.
Our current episode out right now is with Nick Jonas – sharing his thoughts on the new campaign to educate about Time in Range and talking about he manages his T1D during concerts, shooting movies and during TV tapings.
Thanks and I’ll see you soon